IndexIQ Advisors’s Enanta Pharmaceuticals ENTA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-8,563
| Closed | -$640K | – | 1372 |
|
|
2021
Q4 | $640K | Sell |
8,563
-553
| -6% | -$41.3K | 0.02% | 416 |
|
|
2021
Q3 | $518K | Buy |
9,116
+913
| +11% | +$51.9K | 0.02% | 525 |
|
|
2021
Q2 | $361K | Sell |
8,203
-147
| -2% | -$6.47K | 0.01% | 876 |
|
|
2021
Q1 | $412K | Buy |
8,350
+4,278
| +105% | +$211K | 0.01% | 498 |
|
|
2020
Q4 | $171K | Buy |
4,072
+420
| +12% | +$17.6K | 0.01% | 950 |
|
|
2020
Q3 | $167K | Buy |
3,652
+200
| +6% | +$9.15K | 0.01% | 780 |
|
|
2020
Q2 | $173K | Sell |
3,452
-239
| -6% | -$12K | 0.01% | 717 |
|
|
2020
Q1 | $190K | Buy |
+3,691
| New | +$190K | 0.01% | 418 |
|
|
2019
Q1 | – | Sell |
-25,973
| Closed | -$1.84M | – | 605 |
|
|
2018
Q4 | $1.84M | Sell |
25,973
-2,123
| -8% | -$150K | 0.05% | 253 |
|
|
2018
Q3 | $2.4M | Buy |
28,096
+1,061
| +4% | +$90.7K | 0.08% | 254 |
|
|
2018
Q2 | $3.13M | Buy |
27,035
+2,802
| +12% | +$325K | 0.1% | 169 |
|
|
2018
Q1 | $1.96M | Buy |
+24,233
| New | +$1.96M | 0.06% | 402 |
|